Investigation of Memantine in the Treatment of Memory, Concentration or Attention Problems

Clinical trial NCT01261741 · COMPLETED

Trial details

NCT number: NCT01261741
Sponsor: Merz Pharmaceuticals GmbH
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Memory Disorder Retention Disorder, Cognitive Subjective Cognitive Impairment Memory, Concentration or Attention Problems

Start date: 2010-11-01
Primary completion: 2011-08-01
Enrollment: 299

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.